TCDA
Price:
$0.108
Market Cap:
$5.95M
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Industry
Biotechnology
IPO Date
2018-06-28
Stock Exchange
NASDAQ
Ticker
TCDA
According to Tricida, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -99.50% compared to the average of -4.05 of the last 4 quarters.
The mean historical PE Ratio of Tricida, Inc. over the last ten years is -4.83. The current -0.02 PE Ratio has changed -57.73% with respect to the historical average. Over the past ten years (40 quarters), TCDA's PE Ratio was at its highest in in the June 2018 quarter at -0.69. The PE Ratio was at its lowest in in the December 2020 quarter at -334.46.
Average
-4.83
Median
-4.27
Minimum
-10.14
Maximum
-1.33
Discovering the peaks and valleys of Tricida, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 99.69%
Maximum Annual PE Ratio = -1.33
Minimum Annual Increase = -86.87%
Minimum Annual PE Ratio = -10.14
| Year | PE Ratio | Change |
|---|---|---|
| 2021 | -2.46 | 84.92% |
| 2020 | -1.33 | -86.87% |
| 2019 | -10.14 | 99.69% |
| 2018 | -5.08 | 47.13% |
| 2017 | -3.45 | -46.81% |
The current PE Ratio of Tricida, Inc. (TCDA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.65
5-year avg
-4.49
10-year avg
-4.83
Tricida, Inc.’s PE Ratio is greater than Entero Therapeutics, Inc. (-2.70), greater than Neuphoria Therapeutics Inc. (-0.86), greater than Longevity Health Holdings Inc. (-0.07), greater than Xenetic Biosciences, Inc. (-3.28), greater than Fresh Tracks Therapeutics, Inc. (-0.97), less than ModivCare Inc. (-0.00), greater than Tectonic Therapeutic, Inc. (-6.81), greater than Gamida Cell Ltd. (-0.08), greater than BiondVax Pharmaceuticals Ltd. (-19.35), less than Aptose Biosciences Inc. (0.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.70 | $13.58M | |
| -0.86 | $23.62M | |
| -0.07 | $373.13K | |
| -3.28 | $6.04M | |
| -0.97 | $5.59M | |
| -0.00 | $6.20M | |
| -6.81 | $571.36M | |
| -0.08 | $4.34M | |
| -19.35 | $4.97M | |
| 0.79 | $4.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tricida, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tricida, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tricida, Inc.'s PE Ratio?
How is the PE Ratio calculated for Tricida, Inc. (TCDA)?
What is the highest PE Ratio for Tricida, Inc. (TCDA)?
What is the 3-year average PE Ratio for Tricida, Inc. (TCDA)?
What is the 5-year average PE Ratio for Tricida, Inc. (TCDA)?
How does the current PE Ratio for Tricida, Inc. (TCDA) compare to its historical average?